A small economic inducement to stimulate increased reporting of adverse drug reactions - A way of dealing with an old problem?

European Journal of Clinical Pharmacology

Volumn 62, Issue 5, 2006, Pages 381-385

  Backstrom M ^a   Mjorndal T ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse drug reaction; Economic inducement; Spontaneous reporting; Under reporting

Indexed keywords

DRUG;

ARTICLE; DISEASE SEVERITY; DRUG SURVEILLANCE PROGRAM; ECONOMIC ASPECT; GENERAL PRACTITIONER; HUMAN; PHYSICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MOTIVATION; PHYSICIAN INCENTIVE PLANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; SWEDEN; TOKEN ECONOMY;

EID: 33646495334     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0072-0     Document Type: Article

References (25)

1. Bergman U, Wiholm BE (1981) Drug-related problems causing admissions to a medical clinic. Eur J Clin Pharmacol 320:193-200
2. Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27:840-883
3. Hallas J, Gram L, Grodum E, Damsbro N, Brösen K, Hagfeldt T (1992) Drug-related admission to medical wards: a population based survey. Br J Clin Pharmacol 33:61-68
4. Hallas J (1996) Drug-related hospital admission in subspecialities of internal medicine. Dan Med Bull 43:141-155
5. Mannesse CK, Derkx FHM, Ridder M, Man in't Veld A, van der Cammen T (1997) Adverse drug reactions in elderly patients as contributing factors for hospital admission: cross-sectional study. BMJ 315:1057-1058
6. Schneeweiss S, Hasford J, Göttelr M, Hoffman A, Riethling A-K, Avorn J (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospital: a longitudinal population-based study. Eur J Clin Pharmacol 58:285-291
7. van den Bemt PM, Egberts ACG, Lenderink A W, Simons KA, van der Pol WSC, Leufkens HGM (1999) Adverse drug events in hospitalized patients. Eur J Clin Pharmacol 55:155-158
8. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Scheinder T et al (2000) Incidence and cost of adverse drug reactions during hospitalisation. Drug Saf 22 (2):161-168
9. Pouyanne P, Haramburu F, Imbs JL, Béugard B (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 320:1036
10. Mjörndal T, Danell Boman M, Hägg S, Bäckström M, Wiholm B-E, Wahlin A, Dahlqvist R (2002) Adverse drug reactions as a cause for admission to a department of internal medicine. Pharmacoepidemiol Drug Saf 11:65-72
11. Medical Products Agency's Code of Statutes. LVFS 2001:12
12. Samuelsson E, Hägg S, Bäckström M, Granberg K, Mjörndal T (1996) Trombos av p-piller. Betydande underrapportering till biverkningsregistret (in Swedish). Läkartidningen 93(37): 3117-3124
13. Skjeldestal FE, Amundsen T, Höjbraaten E (2000) Rapportering av legemiddelinduserte helseskader til Statens legemiddlerekontrol. Tidsskr Nor Laegeforen 120:336-338
14. Lumley CE, Walker SR, Hall CG, Staunton N, Grob PR (1986) The under-reporting of adverse drug reactions in general practice. Pharm Med 1:206-212
15. Alvarez-Requejo A, Carvajal A, Bégaud B, Moride Y, Vega T, Arias LH (1998) Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 54:483-488
16. Bäckström M, Mjörndal T, Dahlqvist R (2004) Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 13:438-487. Published online in Wiley InterScience (http://www. interscience.wiley.com). DOI:10.1002/pds.962
17. Milstein JB, Falch G, Hsu JP, Knapp DE, Baum C, Dreis MW (1986) Factors affecting physician reporting of adverse drug reactions. Drug Inf J 20:157-164
18. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM (1995) Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 39:223-226
19. Belton KJ, The European Pharmacovigilance Research Group (1997) Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 52:423-427
20. Inman WHW (1996) Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol 41:434
21. Perlik F, Slanar O, Smid M, Petracek J (2002) Attitude of Czech physicians to adverse drug reaction reporting. Eur J Clin Pharmacol 58:367-369
22. Bäckström M, Dahlqvist R, Mjörndal T, Nordkvist Olsson T (2000) Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 56:729-732
23. Bäckström M, Dahlqvist R, Mjörndal T, Spigset O, Hedenmalm K, Granberg K (1995) Regionalt centrum för biverkningsrapportering i Umeå. Kort handläggning ger snabb återkoppling (in Swedish). Läkartidningen 92:148-150
24. Feely J, Moriarty S, O'Connor P (1990) Stimulating reporting of adverse drug reaction by using a fee. BMJ 300:22-23
25. Bäckström M, Mjörndal T, Dahlqvist R (2002) Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf 11:647-650